Login / Signup

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial.

Eugene HanJi Hye HuhEun Y LeeJi C BaeSung W ChunSung H YuSoo H KwakKyong S ParkByung-Wan Lee
Published in: Diabetes, obesity & metabolism (2021)
Keyphrases
  • double blind
  • phase iii
  • placebo controlled
  • phase ii
  • clinical trial
  • study protocol
  • open label
  • liver fibrosis